Stay updated with breaking news from Stuart Rich. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Positive Data Presented at HFSA Annual Meeting Demonstrate Effects of Oral Levosimendan in Patients with Pulmonary Hypertension and Heart Failure with Preserved Ejection Fraction (PH-HFpEF) - read this article along with other careers information, tips and advice on BioSpace
Receives a Notice of Allowance of Multiple Patent Claims for TNX-102 (subcutaneous levosimendan) Successfully Completes IV to Oral Transition Substudy for...
25 Tenax Therapeutics, Inc. (NASDAQ: TENX)announced positive data from its Phase 2 HELP Study that evaluated levosimendan in patients with pulmonary hypertension and heart failure with preserved ejection fraction. Levosimendan Improves Hemodynamics and Exercise Tolerance in PH-HFpEF: Results of the Placebo-Controlled HELP Trial was published in the Journal of American College of Cardiology: Heart Failure. The publication had a 84% responder rate during the open label phase as 37 or 44 patients met responder criteria and were randomized to levosimendan (n=18) or ...
4 Penny Stocks To Buy With Analysts Expecting 80%-180% Upside These Penny Stocks Have Analysts Bullish Right Now 71 views Author Are Analysts Right About These Penny Stocks? Penny stocks are some of the highest-risk stocks in the market. Thanks to a long history of volatility, manipulation, hype, and speculation, traders seek the ultimate alpha in these cheap shares. But it isn’t just for “wild west” gun-slinging traders. Analysts have also grown bullish on many stocks under $5. Small-cap stocks are synonymous with “penny stocks.” Usually, a benchmark for sentiment, the Russell 2...
Published: Mar 02, 2021 New Board appointments strengthen Tenax with world-class expertise in cardiovascular drug development, commercial strategy, and business development New Directors will provide significant guidance as Tenax is poised to advance its two leading drug candidates into late-stage clinical testing Transformational step as Tenax strengthens its positioning as a leading specialty pharmaceutical company focused on cardio-pulmonary therapeutics a specialty pharmaceutical company focused on identifying and developing therapeutics that address cardio-pulmonary diseases ...